Skip to Main Content
S. Karger AG Open Menu
header search
Search
Advanced Search
Skip Nav Destination

Issues

Volume 1, Issue 4
1948
Acta Haematologica Cover Image for Volume 1, Issue 4
All Issues
ISSN 0001-5792
EISSN 1421-9662
In this Issue

Acta Haematologica 1948, Vol. 1, No. 4

Paper

Uncertainty in the Prediction of the Occurrence and Severity of Hemolytic Disease of the Newborn from Antenatal Blood Tests
Subject Area: Hematology , Oncology
Ruth Van Olinda Ponder; Eric Ponder; Philip Levine
Acta Haematol (1948) 1 (4): 217–224. https://doi.org/10.1159/000203391
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Klinische und experimentelle Untersuchungen über den Wirkungsmechanismus des Urethans
Subject Area: Hematology , Oncology
Sven Moesghlin
Acta Haematol (1948) 1 (4): 225–247. https://doi.org/10.1159/000203392
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
The Effect of Urethane on the Number of Leucocytes in Patients Suffering from Psoriasis
Subject Area: Hematology , Oncology
E. Gilg; A. Perdrup
Acta Haematol (1948) 1 (4): 248–252. https://doi.org/10.1159/000203393
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
The Use of Urethane in the Treatment of Leukemia
Subject Area: Hematology , Oncology
Frederick Sherwood
Acta Haematol (1948) 1 (4): 253–266. https://doi.org/10.1159/000203394
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Die amerikanische hämatologische Literatur in den Jahren 1946/47 (Blood Bd. 1 und 2)
Subject Area: Hematology , Oncology
St.J. Leitner
Acta Haematol (1948) 1 (4): 266–284. https://doi.org/10.1159/000203395
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window

Further Section

The International Society of Hematology
Subject Area: Hematology , Oncology
Acta Haematol (1948) 1 (4): 284–291. https://doi.org/10.1159/000203396
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Varia
Subject Area: Hematology , Oncology
Acta Haematol (1948) 1 (4): 291–292. https://doi.org/10.1159/000203397
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Contents, Vol. 1, 1948
Subject Area: Hematology , Oncology
Acta Haematol (1948) 1 (4): I–IV. https://doi.org/10.1159/000203390
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
AI Applications in Transfusion Medicine: Opportunities, Challenges, and Future Directions
Favorable rates of cardiovascular events with stringent cardiovascular monitoring and a lowered dose of ponatinib as second line treatment in chronic phase chronic myeloid leukemia (CML-CP) patients failing or intolerant to first-line second generation tyrosine kinase inhibitor (TKI) treatment: Results of the prospective PONS trial
Dose reduced induction therapy (A)-AIDA in patients with AML, being unfit for standard 7+3 chemotherapy and Literature Review of AML treatment in unfit/older AML patients
Beyond Cellular Therapies: The Expanding Role of Antibody-Driven Immunotherapy in Pediatric Acute Lymphoblastic Leukemia
  • Online ISSN 1421-9662
  • Print ISSN 0001-5792
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal